3Pernow J, Wang Q D. Endothelin in ischaemia and reperfusion [J]. Cardiovasc Res, 1997, 33 (3) : 518-526.
4Niccoli G, Lanza G A, Shaw S, et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization [ J ]. Eur Heart J, 2006, 27 ( 15 ) : 1793-1798.
5Katsuomi Iwakura, Ito H, Kawano S, et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction [J]. Eur Heart J, 2006 , 27(5) :534-539.
3Chakrabarti AK, Gibson CM, Pinto DS. Optimal selection of STEMI treatment strategies in the current era: benefit of transferring STEMI patients for PCI compared with administration of onsite fibrinolytic therapy. Curr Opin Cardiol, 2012, 27 (6):651-654.
4Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coil Cardiol, 2004, 44 (7) :1595-1399.
5Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation, 2002, 105 (19) :2259-2264.
6Sharma D. Hydration is critical for prevention of contrast-induced nephropathy. JACC Cardiovasc Interv, 2012, 5 (4) :454-455.
7Li W, Fu X, Wang Y, et al. Beneficial effects of high-dose atorvastatin pretreatment on renal function in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention. Cardiology, 2012, 122 (3) :195-202.
8Cigarroa RG, Lange RA, Williams RH, et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med, 1959, $6 (6):649-652.
9Thomsen HS, European Society of Urogenital Radiology. European Society of Urogenital Radiology guidelines on contrast media application. Curr Opin Urol, 2007, 17 ( 1 ) :70-76.
10Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation, 2002, 105 (19):2259-2264.
